{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:48:06Z","timestamp":1782895686953,"version":"3.54.5"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Urothelial carcinoma of the bladder (UBC) and upper tract urothelial carcinoma (UTUC) are distinct malignancies with differing prognoses and molecular characteristics despite their shared histological origin. Emerging evidence suggests that chronic inflammation, often driven by specific carcinogenic exposures, plays a critical role in tumour development. While the oncogenic role of various chemical agents in UTUC is well established, the potential contribution of recurrent urolithiasis remains underappreciated and insufficiently studied. Given the frequent observation of inflammatory polyps surrounding upper tract calculi, further investigation into this association is warranted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>This case series reports on three patients with UTUC in the context of recurrent urolithiasis. Case 1 involves a 53-year-old male patient with a history of repeated ureteric stones and inflammatory polyps who was later diagnosed with low-grade invasive urothelial carcinoma. Case 2 describes a 46-year-old female patient with bilateral renal calculi who developed high-grade invasive UTUC following long-standing calculus disease. Case 3 is a 57-year-old male patient who had recently ingested herbal medicine containing aristolochic acid and was found to have high-grade UTUC, with concurrent urolithiasis potentially contributing to carcinogenesis. In each instance, urothelial carcinoma was initially concealed by polypoid lesions surrounding impacted stones, highlighting the associated diagnostic challenges.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case series underscores the potential oncogenic role of chronic inflammation induced by recurrent upper urinary tract calculi. Persistent stone-related mucosal injury may contribute to UTUC pathogenesis. Clinicians should maintain a high index of suspicion and perform targeted biopsies of polypoid lesions encountered during the endoscopic management of urolithiasis. Enhanced awareness may facilitate earlier detection and intervention, particularly in patients with recurrent calculus disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1850083","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:20:33Z","timestamp":1782894033000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case report: A case series report: recurrent urolithiasis as a risk factor for upper tract urothelial carcinoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Yuke","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Urology, Shanghai Tenth People\u2019s Hospital, Tongji University","place":["Shanghai, China"]},{"name":"Cancer Institute, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxian","family":"Shen","sequence":"additional","affiliation":[{"name":"Cancer Institute, School of Medicine, Tongji University","place":["Shanghai, China"]},{"name":"Department of Nephrology, Nantong Tongzhou District People\u2019s Hospital","place":["Nantong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, Shanghai Tenth People\u2019s Hospital, Tongji University","place":["Shanghai, China"]},{"name":"Cancer Institute, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Urology, Shanghai Tenth People\u2019s Hospital, Tongji University","place":["Shanghai, China"]},{"name":"Cancer Institute, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Peking University First Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, Shanghai Tenth People\u2019s Hospital, Tongji University","place":["Shanghai, China"]},{"name":"Cancer Institute, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangchun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Shanghai Tenth People\u2019s Hospital, Tongji University","place":["Shanghai, China"]},{"name":"Cancer Institute, School of Medicine, Tongji University","place":["Shanghai, China"]},{"name":"Department of Urology, People\u2019s Hospital of Shigatse City","place":["Shigatse, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-016-1928-x","article-title":"Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)","volume":"35","author":"Soria","year":"2017","journal-title":"World J Urol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12967-023-04815-y","article-title":"Transcriptomic insights into UTUC: role of inflammatory fibrosis and potential for personalized treatment","volume":"22","author":"Li","year":"2024","journal-title":"J Transl Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.07.039","article-title":"Genomic characterization of upper tract urothelial carcinoma","volume":"68","author":"Sfakianos","year":"2015","journal-title":"Eur Urol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.128728","article-title":"Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy","volume":"5","author":"Winters","year":"2019","journal-title":"JCI Insight"},{"key":"B5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.eururo.2025.02.023","article-title":"European association of urology guidelines on upper urinary tract urothelial carcinoma: summary of the 2025 update","volume":"87","author":"Masson-Lecomte","year":"2025","journal-title":"Eur Urol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.06.027","article-title":"Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis","volume":"520","author":"Cai","year":"2021","journal-title":"Cancer Lett"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.03.013","article-title":"Impact of risk factors on early cancer evolution","volume":"186","author":"Weeden","year":"2023","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1183\/13993003.00359-2016","article-title":"Risk factors for lung cancer worldwide","volume":"48","author":"Malhotra","year":"2016","journal-title":"Eur Respir J"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2018.0020","article-title":"Lung cancer screening, version 3.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Wood","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"B10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41392-021-00713-1","article-title":"AHR mediates the aflatoxin B1 toxicity associated with hepatocellular carcinoma","volume":"6","author":"Zhu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106298","article-title":"Relative contribution of hepatitis B and C viruses in primary liver cancer in China: a systematic review and meta-analysis","volume":"89","author":"Wen","year":"2024","journal-title":"J Infect"},{"key":"B12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","article-title":"European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines","volume":"85","author":"Alfred Witjes","year":"2024","journal-title":"Eur Urol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094642","article-title":"The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies","volume":"22","author":"Juan","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","article-title":"ROS signalling in the biology of cancer","volume":"80","author":"Moloney","year":"2018","journal-title":"Semin Cell Dev Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-022-01304-4","article-title":"Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.canlet.2013.08.016","article-title":"Helicobacter pylori-induced gastric inflammation and gastric cancer","volume":"345","author":"Wang","year":"2014","journal-title":"Cancer Lett"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v30.i13.1851","article-title":"History of chronic gastritis: how our perceptions have changed","volume":"30","author":"Bordin","year":"2024","journal-title":"World J Gastroenterol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1850083\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:20:45Z","timestamp":1782894045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1850083\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":18,"alternative-id":["10.3389\/fonc.2026.1850083"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1850083","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"article-number":"1850083"}}